This Week on NeurologyLive — February 22, 2021


Here's what is coming soon to NeurologyLive.

Every week, the NeurologyLive staff prepares this preview of what to expect from our coverage. This week on NeurologyLive, there are a number of hot topics that we will be posting throughout the week. As always, our weekly coverage extends beyond just these topics, so make sure to check out the rest of the site!

The NeurologyLive team will be conducting coverage of the 2021 Americas Committee for Treatment and Research in Multiple Sclerosis Forum this week. The meeting kicks off virtually on Thursday, February 25, 2021, and our coverage will extend beyond the meeting's end on February 27. You can expect to see coverage of some of the top clinical presentations, as well as interviews with the experts about the ongoing conversations and themes in multiple sclerosis care.

To check out our ACTRIMS 2021 coverage, click here.

The latest in our NeuroVoices series, dedicated to conversations with leaders in the neurology community, will go live this Wednesday, February 24. This time, it features a discussion with Cleveland Clinic's Stephen Rao, PhD, and Jay Alberts, PhD. The duo stopped by to discuss a 5-year study they will lead that evaluated the impact high-intensity exercise has in preventing Alzheimer disease. Funded by a grant from the National Institutes of Health, the trial represents the first study to explore if this exercise intervention program can alter the progression of the disease in sedentary, high-risk individuals.

To check out the prior NeuroVoices conversations, click here.

A conversation with Shrey Grover, a PhD student at Boston University in the Department of Brain Behavior and Cognition, will air during NeurologyLive's segment on the Medical World News channel this Thursday, February 25, 2021. Grover spoke to the recently published results of a study he and colleagues conducted on the impacts of neuromodulation on obsessive-compulsive behaviors and its potential to treat these in patients with movement disorders.

To check out what's on the Medical World News channel now, click here.

Episode 30 of the NeurologyLive "Mind Moments" podcast will air on Friday this week. The episode will feature Jennifer Martin, PhD, a member of the American Academy of Sleep Medicine's (AASM) board of directors and professor of medicine at UCLA. She discusses the benefits of cognitive-behavioral therapy for insomnia, its efficacy compared to pharmacological treatments, and the recent AASM guidance on its use.

To subscribe on your favorite podcast player, click here.

Don't forget that all of the NeurologyLive Cure Connections series, "The Multiple Sclerosis Patient Journey," has been made available. This group conversation is led by June Halper, MSN, MSCN, who is joined by Patricia K. Coyle, MD, and Frederick Foley, PhD, as well as patient and care partner Ann Moore and Kathy Zelles. They discuss the specifics of patients' journies with MS and offer their perspectives on various facets of the disease.

To catch up on the rest of the series, click here.

In case you missed it: Our coverage of the American Epilepsy Society (AES) Annual Meeting is still ongoing here on NeurologyLive! A number of expert interviews are still being conducted, including with conference chair Barbara Jobst, MD, to learn and speak more about the data presented at the conference, as well as how the latest updates from the virtual conference floor are expected to impact clinical practice.

To catch up on post-AES 2020 coverage and expert perspectives, click here.

NeurologyLive Wants Your Feedback!

We kindly ask you to share 5 minutes of your time with us, in order to help us better craft our content to meet your needs and interests.

Related Videos
Michael Levy, MD, PhD
Michael Kaplitt, MD, PhD
Michael Kaplitt, MD, PhD
video 4 - "Amyloid Cascade Hypothesis of Alzheimer’s Disease"
Video 3 - "Amyloid Precursor Protein and Amyloid Beta Species in Alzheimer’s Disease"
Svetlana Blitshteyn, MD, FAAN, director and founder of Dysautonomia Clinic
© 2024 MJH Life Sciences

All rights reserved.